Pseudo-temporal dynamics of chemoresistant triple negative breast cancer cells reveal EGFR/HER2 inhibition as synthetic lethal during mid-neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pseudo-temporal dynamics of chemoresistant triple negative breast cancer cells reveal EGFR/HER2 inhibition as synthetic lethal during mid-neoadjuvant chemotherapy

Published:2023-02 Issue:2 Volume:26 Page:106064
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Song Won-Min^ORCID,Chia Pei-Ling,Zhou Xianxiao,Walsh Martin,Silva Jose,Zhang Bin

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference76 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

2. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J. Clin. Oncol.,2008

3. Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?;Bai;Cancer Lett.,2021

4. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection;Lehmann;PLoS One,2016

5. Advances in the systemic treatment of triple-negative breast cancer;Lebert;Curr.Oncol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP